Kiemes, Amanda http://orcid.org/0000-0001-6819-8090
Gomes, Felipe V.
Cash, Diana http://orcid.org/0000-0001-5021-1234
Uliana, Daniela L.
Simmons, Camilla
Singh, Nisha
Vernon, Anthony C. http://orcid.org/0000-0001-7305-1069
Turkheimer, Federico
Davies, Cathy http://orcid.org/0000-0003-3011-8643
Stone, James M. http://orcid.org/0000-0003-3051-0135
Grace, Anthony A.
Modinos, Gemma http://orcid.org/0000-0002-7870-066X
Funding for this research was provided by:
Sao Paulo Research Foundation
National Institutes of Health
Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society
Article History
Received: 22 July 2021
Revised: 9 October 2021
Accepted: 13 October 2021
First Online: 6 November 2021
Competing interests
: AAG received consultant fees from Lundbeck, Pfizer, Otsuka, Asubio, Autofony, Alkermes, Concert, and Janssen, and is on the advisory board for Alkermes, Newron, and Takeda. In the last 3  years, JMS has been principal investigator or sub-investigator on studies sponsored by Takeda, Janssen, and Lundbeck Plc. He has attended an Investigators’ meeting run by Allergan Plc. All other authors report no competing interests.